Valuation: ALTEOGEN Inc.

Market Cap 17,652B 12.71B 11.08B 10.46B 9.5B 17.8B 1,219B 17.87B 125B 48.36B 620B 47.73B 46.67B 1,994B P/E 2026 *
59.6x
P/E 2027 * 43.8x
Enterprise Value 17.17B 12.36M 10.78M 10.18M 9.24M 17.32M 1.19B 17.39M 122M 47.05M 603M 46.44M 45.41M 1.94B EV / Sales 2026 *
36.6x
EV / Sales 2027 * 25.6x
Free-Float
74.26%
Yield 2026 *
0.19%
Yield 2027 * 0.22%
1 day-0.20%
1 week-5.41%
Current month-17.56%
1 month-14.93%
3 months-10.81%
6 months-7.17%
Current year-26.69%
1 week 250,500
Extreme 250500
267,500
1 month 250,500
Extreme 250500
344,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 38,615.38
Extreme 38615.384615
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
21/05/25 Exercice

Chief Executive Officer

7,200 0.0135%
27/03/24 Sell 1,600,000 3.0182%
05/01/24 Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%-5.41%-30.40%+368.11% 12.81B
-0.58%+0.43%+31.09%-4.81% 78.83B
-2.55%+6.99%+505.27%+47.92% 63.11B
-1.11%+5.08%-11.47%-33.91% 60.48B
+0.14%-1.20%-11.64%+24.21% 46.75B
-0.24%+1.22%+2.26%+151.03% 45.66B
-1.62%-0.76%+49.85%-14.92% 32.37B
-1.81%+3.16%+45.71%+110.57% 25.87B
+0.47%+3.26%-0.77%+142.41% 21.33B
+0.27%+1.96%+62.19%+102.81% 15.8B
Average -0.72%+1.53%+64.21%+89.34% 40.3B
Weighted average by Cap. -0.91%+2.08%+90.76%+50.56%

Financials

2026 *2027 *
Net sales 469B 338M 294M 278M 252M 473M 32.39B 475M 3.33B 1.28B 16.47B 1.27B 1.24B 52.98B 660B 475M 414M 391M 355M 666M 45.61B 669M 4.69B 1.81B 23.19B 1.79B 1.75B 74.61B
Net income 298B 214M 187M 176M 160M 300M 20.56B 301M 2.11B 816M 10.45B 805M 787M 33.64B 379B 273M 238M 224M 204M 382M 26.16B 384M 2.69B 1.04B 13.3B 1.02B 1B 42.8B
Net Debt -478B -344M -300M -283M -257M -482M -33.01B -484M -3.39B -1.31B -16.79B -1.29B -1.26B -54.01B -730B -525M -458M -432M -393M -736M -50.39B -739M -5.18B -2B -25.62B -1.97B -1.93B -82.44B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
181
Date Price Change Volume
18/09/26 ₩253,500.00 -0.20% 216,543
17/09/26 ₩254,000.00 -0.59% 205,493
16/09/26 ₩255,500.00 -1.73% 325,625
15/09/26 ₩260,000.00 0.00% 266,955
14/09/26 ₩260,000.00 -2.99% 403,038
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
253,500.00KRW
Average target price
394,615.38KRW
Spread / Average Target
+55.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!